213 related articles for article (PubMed ID: 8757209)
1. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial.
Bernstein IL; Bernstein DI; Dubb JW; Faiferman I; Wallin B
J Allergy Clin Immunol; 1996 Aug; 98(2):317-24. PubMed ID: 8757209
[TBL] [Abstract][Full Text] [Related]
2. Auranofin in the treatment of steroid dependent asthma: a double blind study.
Nierop G; Gijzel WP; Bel EH; Zwinderman AH; Dijkman JH
Thorax; 1992 May; 47(5):349-54. PubMed ID: 1609377
[TBL] [Abstract][Full Text] [Related]
3. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
[TBL] [Abstract][Full Text] [Related]
5. An open study of auranofin in the treatment of steroid-dependent asthma.
Bernstein DI; Bernstein IL; Bodenheimer SS; Pietrusko RG
J Allergy Clin Immunol; 1988 Jan; 81(1):6-16. PubMed ID: 3276761
[TBL] [Abstract][Full Text] [Related]
6. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
[TBL] [Abstract][Full Text] [Related]
7. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
8. SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
Wechsler ME; Colice G; Griffiths JM; Almqvist G; Skärby T; Piechowiak T; Kaur P; Bowen K; Hellqvist Å; Mo M; Garcia Gil E
Respir Res; 2020 Oct; 21(1):264. PubMed ID: 33050928
[TBL] [Abstract][Full Text] [Related]
9. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group.
Nelson HS; Bernstein IL; Fink J; Edwards TB; Spector SL; Storms WW; Tashkin DP
Chest; 1998 May; 113(5):1264-71. PubMed ID: 9596304
[TBL] [Abstract][Full Text] [Related]
10. Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study.
Menzies-Gow A; Gurnell M; Heaney LG; Corren J; Bel EH; Maspero J; Harrison T; Jackson DJ; Price D; Lugogo N; Kreindler J; Burden A; de Giorgio-Miller A; Padilla K; Martin UJ; Garcia Gil E
Lancet Respir Med; 2022 Jan; 10(1):47-58. PubMed ID: 34619104
[TBL] [Abstract][Full Text] [Related]
11. Gold as an oral corticosteroid sparing agent in stable asthma.
Evans DJ; Cullinan P; Geddes DM
Cochrane Database Syst Rev; 2001; 2000(2):CD002985. PubMed ID: 11406053
[TBL] [Abstract][Full Text] [Related]
12. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
Jover JA; Hernández-García C; Morado IC; Vargas E; Bañares A; Fernández-Gutiérrez B
Ann Intern Med; 2001 Jan; 134(2):106-14. PubMed ID: 11177313
[TBL] [Abstract][Full Text] [Related]
14. Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma.
Vogelmeier C; Kardos P; Hofmann T; Canisius S; Scheuch G; Muellinger B; Nocker K; Menz G; Rabe KF
Eur Respir J; 2015 May; 45(5):1273-82. PubMed ID: 25504995
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate in the management of severe steroid dependent asthma.
Taylor DR; Flannery EM; Herbison GP
N Z Med J; 1993 Sep; 106(964):409-11. PubMed ID: 8377957
[TBL] [Abstract][Full Text] [Related]
17. Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.
Gonem S; Berair R; Singapuri A; Hartley R; Laurencin MFM; Bacher G; Holzhauer B; Bourne M; Mistry V; Pavord ID; Mansur AH; Wardlaw AJ; Siddiqui SH; Kay RA; Brightling CE
Lancet Respir Med; 2016 Sep; 4(9):699-707. PubMed ID: 27503237
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β
Bleecker ER; FitzGerald JM; Chanez P; Papi A; Weinstein SF; Barker P; Sproule S; Gilmartin G; Aurivillius M; Werkström V; Goldman M;
Lancet; 2016 Oct; 388(10056):2115-2127. PubMed ID: 27609408
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma.
Lock SH; Kay AB; Barnes NC
Am J Respir Crit Care Med; 1996 Feb; 153(2):509-14. PubMed ID: 8564089
[TBL] [Abstract][Full Text] [Related]
20. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
Petri MA; Lahita RG; Van Vollenhoven RF; Merrill JT; Schiff M; Ginzler EM; Strand V; Kunz A; Gorelick KJ; Schwartz KE;
Arthritis Rheum; 2002 Jul; 46(7):1820-9. PubMed ID: 12124866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
